Would someone please explain what determines the timing of the release of the AML trial results?
I’ve only held for the last few months and have read through the releases a number of times but am unable to find what exactly determines the release date of this study’s findings ... is the study still running or is the data currently being processed?
Does the study have a set completion date or is this dependent on patients and their individual treatment program?
As this is the first biotech I’ve held, I’m new to processes involved in these studies, so any information on this is greatly appreciated .
PTX Price at posting:
11.5¢ Sentiment: None Disclosure: Not Held
